The content on this site is intended for healthcare professionals only
Neck cancer is increasingly common, especially among younger patients under 45, with a low female representation. Many struggle to access healthcare and often turn to traditional medicine, leading to late treatment. Financial issues impact decisions on surgery, as many are primary earners. From January 2019 to August 2024, 529 reconstructions were performed with a 99.18% success rate, utilizing various flap techniques to improve functional and aesthetic results.
Powering equity in cancer care through digital health
Advancements in head and neck cancer treatment in India
Multiple Myeloma: evolving paradigm - Panel Discussion
Enhancing head and neck oncology: Key insights from the conference
Common Sense Oncology in head & neck cancers
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
GIST tumours and soft tissue sarcomas
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Relapsed refractory multiple myeloma
